Latest Breaking News On - Yadarisa shabongediting - Page 1 : comparemela.com

(Reuters) -The EU's drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs including Novo Nordisk's popular therapies Ozempic and Wegovy to further investigate suicidal thoughts in some patients taking them. "While at this point no conclusion can be drawn on a causal association, there are several issues that still need to be clarified," the European Medicines Agency (EMA) said in a statement on Friday, making it the first major global regulator to provided an update on such reviews. EMA's Pharmacovigilance Risk Assessment Committee (PRAC) will discuss the topic again at its meeting in April 2024, it added.

United kingdomFrances kerrySanofi suliquaAstrazeneca bydureonNovo rybelsusLudwig burgerYadarisa shabongeditingEli lilly trulicityIcelandic medicines agencyEuropean medicines agencyPharmacovigilance risk assessment committeeDrug administrationNovo nordiskRisk assessment committeeEli lillySuicidal thoughts